Johnson & Johnson (JNJ)
(Delayed Data from NYSE)
$166.15 USD
-0.92 (-0.55%)
Updated Sep 18, 2024 04:00 PM ET
After-Market: $166.16 +0.01 (0.01%) 7:58 PM ET
4-Sell of 5 4
C Value F Growth D Momentum D VGM
- YR Estimate
- 12/31/2023
- 12/31/2022
- 12/31/2021
- 12/31/2020
- 12/31/2019
- Revenue - Line of Business (LOBR)
- Sales: Innovative Medicine: WW
- 54,759.00
- 52,563.00
- 52,080.00
- 45,572.00
- 42,198.00
- Revenue - Line of Business (LOBR)
- Sales: MedTech: Total
- 30,400.00
- 27,427.00
- 27,060.00
- 22,959.00
- 25,963.00
- Revenue - Line of Business (LOBR)
- Sales: Innovative Medicine: Immunology: WW
- 18,052.00
- 16,935.00
- 16,750.00
- 15,055.00
- 13,950.00
- Revenue - Line of Business (LOBR)
- Sales: Innovative Medicine: Immunology: REMICADE: WW
- 1,839.00
- 2,343.00
- 3,190.00
- 3,747.00
- 4,380.00
- Revenue - Line of Business (LOBR)
- Sales: Innovative Medicine: Immunology: SIMPONI / SIMPONI ARIA: WW
- 2,197.00
- 2,184.00
- 2,276.00
- 2,243.00
- 2,188.00
- Revenue - Line of Business (LOBR)
- Sales: Innovative Medicine: Immunology: STELARA: WW
- 10,858.00
- 9,723.00
- 9,134.00
- 7,707.00
- 6,361.00
- Revenue - Line of Business (LOBR)
- Sales: Innovative Medicine: Immunology: TREMFYA: WW
- 3,147.00
- 2,668.00
- 2,127.00
- 1,347.00
- 1,012.00
- Revenue - Line of Business (LOBR)
- Sales: Innovative Medicine: Immunology: Other Immunology: WW
- 11.00
- 17.00
- 24.00
- 11.00
- 10.00
- Revenue - Line of Business (LOBR)
- Sales: Innovative Medicine: Infectious Diseases: WW
- 4,418.00
- 5,449.00
- 5,825.00
- 3,574.00
- 3,413.00
- Revenue - Line of Business (LOBR)
- Sales: Innovative Medicine: Neuroscience: WW
- 7,140.00
- 6,893.00
- 6,988.00
- 6,548.00
- 6,328.00
- Revenue - Line of Business (LOBR)
- Sales: Innovative Medicine: Infectious Diseases: Edurant / rilpivirine: WW
- 1,150.00
- 1,008.00
- 994.00
- 964.00
- 861.00
- Revenue - Line of Business (LOBR)
- Sales: Innovative Medicine: Neuroscience: INVEGA SUSTENNA / XEPLION / INVEGA TRINZA / TREVICTA: WW
- 4,115.00
- 4,140.00
- 4,022.00
- 3,653.00
- 3,330.00
- Revenue - Line of Business (LOBR)
- Sales: Innovative Medicine: Cardiovascular / Metabolism / Other: Xarelto: WW
- 2,365.00
- 2,473.00
- 2,438.00
- 2,345.00
- 2,313.00
- Revenue - Line of Business (LOBR)
- Sales: Innovative Medicine: Oncology: WW
- 18,052.00
- 15,983.00
- 14,548.00
- 12,367.00
- 10,692.00
- Revenue - Line of Business (LOBR)
- Sales: Innovative Medicine: Oncology: ZYTIGA / abiraterone acetate: WW
- 887.00
- 1,770.00
- 2,297.00
- 2,470.00
- 2,795.00
- Revenue - Line of Business (LOBR)
- Sales: Innovative Medicine: Infectious Diseases: PREZISTA / PREZCOBIX / REZOLSTA / SYMTUZA: WW
- 1,854.00
- 1,943.00
- 2,083.00
- 2,184.00
- 2,110.00
- Revenue - Line of Business (LOBR)
- Sales: Innovative Medicine: Oncology: Other Oncology: WW
- 879.00
- 571.00
- 568.00
- 821.00
- 407.00
- Revenue - Line of Business (LOBR)
- Sales: Innovative Medicine: Neuroscience: Other Neuroscience: WW
- 1,553.00
- 1,623.00
- 1,706.00
- 1,632.00
- 1,614.00
- Revenue - Line of Business (LOBR)
- Sales: Innovative Medicine: Pulmonary Hypertension: Other Pulmonary Hypertension: WW
- 260.00
- 313.00
- 395.00
- 1,186.00
- 476.00
- Revenue - Line of Business (LOBR)
- Sales: Innovative Medicine: Oncology: DARZALEX: WW
- 9,744.00
- 7,977.00
- 6,023.00
- 4,190.00
- 2,998.00
- Revenue - Line of Business (LOBR)
- Sales: MedTech: Vision: Surgical: WW
- 1,370.00
- 1,306.00
- 1,248.00
- 925.00
- 1,232.00
- Revenue - Line of Business (LOBR)
- Sales: MedTech: Vision: Contact Lenses / Other: WW
- 3,702.00
- 3,543.00
- 3,440.00
- 2,994.00
- 3,392.00
- Revenue - Line of Business (LOBR)
- Sales: Innovative Medicine: Pulmonary Hypertension: UPTRAVI: WW
- 1,582.00
- 1,322.00
- 1,237.00
- 1,093.00
- 819.00
- Revenue - Line of Business (LOBR)
- Sales: Innovative Medicine: Pulmonary Hypertension: OPSUMIT: WW
- 1,973.00
- 1,783.00
- 1,819.00
- 1,639.00
- 1,327.00
- Revenue - Line of Business (LOBR)
- Sales: Innovative Medicine: Pulmonary Hypertension: WW
- 3,815.00
- 3,417.00
- 3,450.00
- 3,148.00
- 2,623.00
- Revenue - Line of Business (LOBR)
- Sales: Innovative Medicine: Cardiovascular / Metabolism / Other: Other: WW
- 1,306.00
- 1,414.00
- 1,119.00
- 1,186.00
- 1,353.00
- Revenue - Line of Business (LOBR)
- Sales: MedTech: Surgery: WW
- 10,037.00
- 9,690.00
- 9,812.00
- 8,232.00
- 9,501.00
- Revenue - Line of Business (LOBR)
- Sales: MedTech: Surgery: Advanced: WW
- 4,671.00
- 4,569.00
- 4,622.00
- 3,839.00
- 4,095.00
- Revenue - Line of Business (LOBR)
- Sales: MedTech: Orthopaedics: Spine, Sports & Other: WW
- 2,947.00
- 2,843.00
- 2,893.00
- 2,699.00
- 3,201.00
- Revenue - Line of Business (LOBR)
- Sales: MedTech: Orthopaedics: Trauma: WW
- 2,979.00
- 2,871.00
- 2,885.00
- 2,614.00
- 2,720.00
- Revenue - Line of Business (LOBR)
- Sales: MedTech: Orthopaedics: Knees: WW
- 1,456.00
- 1,359.00
- 1,325.00
- 1,170.00
- 1,480.00
- Revenue - Line of Business (LOBR)
- Sales: MedTech: Orthopaedics: Hips: WW
- 1,560.00
- 1,514.00
- 1,485.00
- 1,280.00
- 1,438.00
- Revenue - Line of Business (LOBR)
- Sales: Innovative Medicine: Infectious Diseases: Other Infectious Diseases: WW
- 297.00
- 318.00
- 363.00
- 427.00
- 441.00
- Revenue - Line of Business (LOBR)
- Sales: Innovative Medicine: Cardiovascular / Metabolism / Other: WW
- 3,671.00
- 3,887.00
- 4,119.00
- 4,878.00
- 5,192.00
- Revenue - Line of Business (LOBR)
- Sales: Innovative Medicine: Oncology: ERLEADA: WW
- 2,387.00
- 1,881.00
- 1,291.00
- 760.00
- 332.00
- Revenue - Line of Business (LOBR)
- Sales: MedTech: Orthopaedics: WW
- 8,942.00
- 8,587.00
- 8,588.00
- 7,763.00
- 8,839.00
- Revenue - Line of Business (LOBR)
- Sales: MedTech: Surgery: General: WW
- 5,366.00
- 5,121.00
- 5,190.00
- 4,392.00
- 4,480.00
- Revenue - Line of Business (LOBR)
- Sales: MedTech: Vision: WW
- 5,072.00
- 4,849.00
- 4,688.00
- 3,919.00
- 4,624.00
- Revenue - Line of Business (LOBR)
- Sales: Innovative Medicine: Neuroscience: CONCERTA / methylphenidate: WW
- 783.00
- 644.00
- 667.00
- 622.00
- 696.00
- Revenue - Line of Business (LOBR)
- Sales: Innovative Medicine: Oncology: IMBRUVICA: WW
- 3,264.00
- 3,784.00
- 4,369.00
- 4,128.00
- 3,411.00
- Revenue - Geographic (GEOR)
- Sales: U.S.
- 46,444.00
- 48,580.00
- 47,156.00
- 43,133.00
- 42,097.00
- Revenue - Geographic (GEOR)
- Sales: International
- 38,715.00
- 46,363.00
- 46,619.00
- 39,451.00
- 39,962.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: US
- 31,169.00
- 28,604.00
- 27,954.00
- 25,735.00
- 23,874.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: International
- 23,590.00
- 23,959.00
- 24,126.00
- 19,837.00
- 18,324.00
- Revenue - Geographic (GEOR)
- Sales: MedTech: U.S.
- 15,275.00
- 13,377.00
- 12,686.00
- 11,036.00
- 12,384.00
- Revenue - Geographic (GEOR)
- Sales: MedTech: International
- 15,125.00
- 14,050.00
- 14,374.00
- 11,923.00
- 13,579.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Immunology: US
- 11,539.00
- 11,036.00
- 10,843.00
- 10,175.00
- 9,641.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Immunology: International
- 6,513.00
- 5,899.00
- 5,907.00
- 4,880.00
- 4,309.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Immunology: REMICADE: US
- 1,143.00
- 1,417.00
- 2,019.00
- 2,508.00
- 3,079.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Immunology: REMICADE: International (Plus US exports)
- 696.00
- 926.00
- 1,171.00
- 893.00
- 1,007.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Cardiovascular / Metabolism / Other: Other: International
- 765.00
- 590.00
- 673.00
- 864.00
- 974.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Pulmonary Hypertension: US
- 2,697.00
- 2,346.00
- 2,365.00
- 2,133.00
- 1,684.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Pulmonary Hypertension: International
- 1,117.00
- 1,071.00
- 1,085.00
- 1,015.00
- 939.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Pulmonary Hypertension: OPSUMIT: US
- 1,292.00
- 1,132.00
- 1,147.00
- 1,008.00
- 766.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Pulmonary Hypertension: OPSUMIT: International
- 681.00
- 651.00
- 672.00
- 631.00
- 562.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Pulmonary Hypertension: UPTRAVI: US
- 1,326.00
- 1,104.00
- 1,056.00
- 955.00
- 714.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Pulmonary Hypertension: UPTRAVI: International
- 255.00
- 218.00
- 181.00
- 138.00
- 105.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Pulmonary Hypertension: Other Pulmonary Hypertension: US
- 79.00
- 110.00
- 163.00
- 169.00
- 205.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Pulmonary Hypertension: Other Pulmonary Hypertension: International
- 182.00
- 202.00
- 232.00
- 247.00
- 272.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Oncology: DARZALEX: US
- 5,277.00
- 4,210.00
- 3,169.00
- 2,232.00
- 1,567.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Oncology: DARZALEX: International
- 4,467.00
- 3,767.00
- 2,854.00
- 1,958.00
- 1,430.00
- Revenue - Geographic (GEOR)
- Sales: MedTech: Vision: Surgical: US
- 460.00
- 468.00
- 459.00
- 344.00
- 490.00
- Revenue - Geographic (GEOR)
- Sales: MedTech: Vision: Surgical: International
- 910.00
- 837.00
- 788.00
- 581.00
- 742.00
- Revenue - Geographic (GEOR)
- Sales: MedTech: Vision: Contact Lenses / Other: US
- 1,626.00
- 1,522.00
- 1,398.00
- 1,213.00
- 1,304.00
- Revenue - Geographic (GEOR)
- Sales: MedTech: Vision: Contact Lenses / Other: International
- 2,076.00
- 2,022.00
- 2,043.00
- 1,781.00
- 2,088.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Immunology: TREMFYA: US
- 2,147.00
- 1,844.00
- 1,503.00
- 926.00
- 764.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Immunology: TREMFYA: International
- 999.00
- 824.00
- 624.00
- 421.00
- 248.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Oncology: ERLEADA: US
- 1,065.00
- 968.00
- 813.00
- 583.00
- 297.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Oncology: ERLEADA: International
- 1,322.00
- 913.00
- 478.00
- 176.00
- 35.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Oncology: CARVYKTI: US
- 469.00
- 133.00
- --
- --
- --
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Oncology: CARVYKTI: International
- 30.00
- --
- --
- --
- --
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Oncology: CARVYKTI: WW
- 500.00
- 133.00
- --
- --
- --
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Neuroscience: SPRAVATO: US
- 589.00
- 328.00
- --
- --
- --
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Neuroscience: SPRAVATO: International
- 100.00
- 46.00
- --
- --
- --
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Neuroscience: SPRAVATO: WW
- 689.00
- 374.00
- --
- --
- --
- Revenue - Geographic (GEOR)
- Sales: MedTech: Cardiovascular: Other Cardiovascular: US
- 109.00
- 102.00
- --
- --
- --
- Revenue - Geographic (GEOR)
- Sales: MedTech: Cardiovascular: Other Cardiovascular: International
- 247.00
- 230.00
- --
- --
- --
- Revenue - Geographic (GEOR)
- Sales: MedTech: Cardiovascular: Other Cardiovascular: WW
- 356.00
- 332.00
- --
- --
- --
- Revenue - Geographic (GEOR)
- Sales: MedTech: Cardiovascular: Electrophysiology: US
- 2,458.00
- 2,036.00
- --
- --
- --
- Revenue - Geographic (GEOR)
- Sales: MedTech: Cardiovascular: Electrophysiology: International
- 2,230.00
- 1,901.00
- --
- --
- --
- Revenue - Geographic (GEOR)
- Sales: MedTech: Cardiovascular: Electrophysiology: WW
- 4,688.00
- 3,937.00
- --
- --
- --
- Revenue - Geographic (GEOR)
- Sales: MedTech: Cardiovascular: ABIOMED: US
- 1,066.00
- 31.00
- --
- --
- --
- Revenue - Geographic (GEOR)
- Sales: MedTech: Cardiovascular: ABIOMED: International
- 240.00
- --
- --
- --
- --
- Revenue - Geographic (GEOR)
- Sales: MedTech: Cardiovascular: ABIOMED: WW
- 1,306.00
- 31.00
- --
- --
- --
- Revenue - Geographic (GEOR)
- Sales: MedTech: Orthopaedics: International
- 3,417.00
- 3,267.00
- 3,462.00
- 2,984.00
- 3,520.00
- Revenue - Geographic (GEOR)
- Sales: MedTech: Surgery: General: International
- 3,168.00
- 3,008.00
- 3,085.00
- 2,679.00
- 2,718.00
- Revenue - Geographic (GEOR)
- Sales: MedTech: Vision: International
- 2,986.00
- 2,859.00
- 2,831.00
- 2,362.00
- 2,830.00
- Revenue - Geographic (GEOR)
- Sales: MedTech: Orthopaedics: US
- 5,525.00
- 5,321.00
- 5,126.00
- 4,779.00
- 5,319.00
- Revenue - Geographic (GEOR)
- Sales: MedTech: Surgery: General: US
- 2,198.00
- 2,113.00
- 2,105.00
- 1,714.00
- 1,762.00
- Revenue - Geographic (GEOR)
- Sales: MedTech: Vision: US
- 2,086.00
- 1,990.00
- 1,857.00
- 1,557.00
- 1,794.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Neuroscience: CONCERTA / methylphenidate: International
- 554.00
- 493.00
- 495.00
- 439.00
- 463.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Neuroscience: INVEGA SUSTENNA / XEPLION / INVEGA TRINZA / TREVICTA: International
- 1,218.00
- 1,426.00
- 1,472.00
- 1,339.00
- 1,224.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Cardiovascular / Metabolism / Other: International
- 765.00
- 845.00
- 927.00
- 1,369.00
- 1,458.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Infectious Diseases: Other Infectious Diseases: International
- 278.00
- 289.00
- 297.00
- 323.00
- 315.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Neuroscience: Other Neuroscience: International
- 1,204.00
- 1,176.00
- 1,368.00
- 1,334.00
- 1,349.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Oncology: Other Oncology: International
- 330.00
- 283.00
- 458.00
- 738.00
- 336.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Infectious Diseases: PREZISTA / PREZCOBIX / REZOLSTA / SYMTUZA: International
- 408.00
- 449.00
- 575.00
- 597.00
- 689.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Oncology: ZYTIGA / abiraterone acetate: International
- 837.00
- 1,696.00
- 2,178.00
- 2,097.00
- 1,985.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Immunology: SIMPONI / SIMPONI ARIA: International
- 1,073.00
- 1,017.00
- 1,148.00
- 1,088.00
- 1,029.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Immunology: SIMPONI / SIMPONI ARIA: US
- 1,124.00
- 1,166.00
- 1,127.00
- 1,155.00
- 1,159.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Immunology: STELARA: International
- 3,892.00
- 3,335.00
- 3,196.00
- 2,467.00
- 2,015.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Immunology: STELARA: US
- 6,966.00
- 6,388.00
- 5,938.00
- 5,240.00
- 4,346.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Immunology: REMICADE: US Exports
- 147.00
- 204.00
- 236.00
- 346.00
- 294.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Neuroscience: CONCERTA / methylphenidate: US
- 230.00
- 151.00
- 172.00
- 183.00
- 233.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Neuroscience: INVEGA SUSTENNA / XEPLION / INVEGA TRINZA / TREVICTA: US
- 2,897.00
- 2,714.00
- 2,550.00
- 2,314.00
- 2,107.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Cardiovascular / Metabolism / Other: Other: US
- 541.00
- 3,042.00
- 3,192.00
- 323.00
- 380.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Infectious Diseases: Other Infectious Diseases: US
- 19.00
- 30.00
- 11.00
- 104.00
- 126.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Neuroscience: Other Neuroscience: US
- 349.00
- 447.00
- 338.00
- 298.00
- 266.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Infectious Diseases: PREZISTA / PREZCOBIX / REZOLSTA / SYMTUZA: US
- 1,446.00
- 1,494.00
- 1,508.00
- 1,587.00
- 1,422.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Oncology: ZYTIGA / abiraterone acetate: US
- 50.00
- 74.00
- 117.00
- 373.00
- 810.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Oncology: Other Oncology: US
- 549.00
- 289.00
- 110.00
- 83.00
- 70.00
- Revenue - Geographic (GEOR)
- Sales: MedTech: Orthopaedics: Hips: US
- 996.00
- 943.00
- 883.00
- 793.00
- 863.00
- Revenue - Geographic (GEOR)
- Sales: MedTech: Orthopaedics: Hips: International
- 564.00
- 571.00
- 602.00
- 487.00
- 575.00
- Revenue - Geographic (GEOR)
- Sales: MedTech: Orthopaedics: Knees: US
- 896.00
- 851.00
- 787.00
- 743.00
- 889.00
- Revenue - Geographic (GEOR)
- Sales: MedTech: Orthopaedics: Knees: International
- 559.00
- 508.00
- 538.00
- 427.00
- 591.00
- Revenue - Geographic (GEOR)
- Sales: MedTech: Orthopaedics: Trauma: US
- 1,949.00
- 1,882.00
- 1,819.00
- 1,648.00
- 1,652.00
- Revenue - Geographic (GEOR)
- Sales: MedTech: Orthopaedics: Trauma: International
- 1,030.00
- 989.00
- 1,066.00
- 966.00
- 1,068.00
- Revenue - Geographic (GEOR)
- Sales: MedTech: Orthopaedics: Spine, Sports & Other: US
- 1,684.00
- 1,645.00
- 1,637.00
- 1,595.00
- 1,915.00
- Revenue - Geographic (GEOR)
- Sales: MedTech: Orthopaedics: Spine, Sports & Other: International
- 1,263.00
- 1,198.00
- 1,256.00
- 1,104.00
- 1,286.00
- Revenue - Geographic (GEOR)
- Sales: MedTech: Surgery: Advanced: US
- 1,833.00
- 1,784.00
- 1,761.00
- 1,535.00
- 1,637.00
- Revenue - Geographic (GEOR)
- Sales: MedTech: Surgery: Advanced: International
- 2,837.00
- 2,785.00
- 2,861.00
- 2,304.00
- 2,458.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Infectious Diseases: EDURANT / rilpivirine: US
- 35.00
- 36.00
- 41.00
- 44.00
- 50.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Oncology: IMBRUVICA: US
- 1,051.00
- 1,390.00
- 1,747.00
- 1,821.00
- 1,555.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Oncology: US
- 8,462.00
- 6,930.00
- 5,958.00
- 5,092.00
- 4,299.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Infectious Diseases: US
- 1,500.00
- 1,680.00
- 2,249.00
- 1,735.00
- 1,597.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Neuroscience: US
- 4,065.00
- 3,570.00
- 3,347.00
- 3,091.00
- 2,919.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Cardiovascular / Metabolism / Other: Xarelto: US
- 2,365.00
- 2,473.00
- 2,438.00
- 2,345.00
- 2,313.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Infectious Diseases: EDURANT / rilpivirine: International
- 1,115.00
- 972.00
- 953.00
- 920.00
- 812.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Oncology: IMBRUVICA: International
- 2,214.00
- 2,394.00
- 2,622.00
- 2,307.00
- 1,856.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Neuroscience: International
- 3,076.00
- 3,323.00
- 3,641.00
- 3,457.00
- 3,409.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Oncology: International
- 9,199.00
- 9,052.00
- 8,590.00
- 7,275.00
- 6,393.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Infectious Diseases: International
- 2,918.00
- 3,769.00
- 3,576.00
- 1,839.00
- 1,815.00
- Revenue - Geographic (GEOR)
- Sales: MedTech: Surgery: US
- 4,031.00
- 3,897.00
- 3,867.00
- 3,249.00
- 3,828.00
- Revenue - Geographic (GEOR)
- Sales: MedTech: Surgery: International
- 6,006.00
- 5,793.00
- 5,945.00
- 4,983.00
- 5,673.00
- Revenue - Geographic (GEOR)
- Sales: Innovative Medicine: Cardiovascular / Metabolism / Other: US
- 2,906.00
- 3,042.00
- 3,192.00
- 3,509.00
- 3,734.00
- Non Financial / Operating Metric (NFM)
- Organic Sales Growth (Operational growth)
- 7.40
- 6.10
- 12.20
- 1.20
- 2.80